You've just been promoted to VP at a public company and received a large equity grant — now what? This is a moment many aspire to achieve, but few fully appreciate its implications. Your equity compensation has just shifted from being a nice bonus to becoming the largest part of your compensation package. This isn't just a bump in pay; it's a fundamental change in your financial picture. Let's break down what this means for you.
How does getting promoted to VP change my financial planning?
Promotion changes your equity landscape
At the director level, equity often feels like an extra perk — something like a bonus with a vesting schedule attached. It's there, and it's welcome, but your salary is still the main event. As a VP, that dynamic flips. Equity becomes the star of the show. It's not just a larger paycheck — it's a shift in how you think about your compensation entirely. Your household now relies heavily on the performance of a single stock, one that vests over time and comes with trading restrictions and tax implications more complex than anything you've experienced before.
The complexity of overlapping equity grants
With your new grant, things get complicated fast. You’re not just dealing with a single vesting schedule anymore. You’ve got multiple grants overlapping, possibly several forms of employer stock (RSU, PSU, and options), each with its own timeline and tax implications. This can quickly become a tangled web. The performance of your company’s stock now plays a significant role in your financial future. It’s not just about the new grant — it’s about how it fits in with what you already have.
The hidden consequences of inaction with employer stock
If you’re not actively managing your employer stock, you’re making a decision by default. The absence of taking regular action with your employer stock is a decision to use a large amount of your paycheck to buy stock in your company. The idea of holding too much employer stock is well known, but the consequences are often overlooked.
At various points in time each year, driven by factors related to your company (or macroeconomic factors alone), your company’s stock price may be attractive (or not), and the best points in time don’t necessarily coincide with when you’re allowed to sell your stock. When a stock is performing well, many people assume this will continue and miss the opportunity to sell their shares when the price is attractive. Long-held positions may have large taxable gains, further contributing to an aversion to sell when things look good, and instead wait to sell until they need money regardless of whether that is a good time to sell.
Pro-Tip: A VP-level equity grant is not just a larger version of what came before — it is a qualitatively different planning situation. The first vesting under the new grant is a good moment to review total equity exposure across all outstanding grants, overlapping vesting schedules, and whether the household's financial plan was built for the compensation structure that now exists.
If you'd like to explore whether ongoing financial planning and investment management make sense for your situation, you can schedule an intro call here:
Common Questions
What are the tax implications of a large RSU grant at VP level?
Receiving a large RSU grant can have significant tax implications. RSUs are taxed as ordinary income when they vest, which means no action is required to trigger the tax event, but you have no control over the timing as you would with stock options. This can push you into a higher tax bracket, and the arrival of a much larger grant resulting from promotion may mean that tax withholding can be off by a material amount. That’s because your employer has no knowledge of your financial situation beyond your individual compensation. Planning for these taxes in advance is crucial to avoid surprises.
Do I need pre-clearance to sell stock after becoming a VP at a public company?
This depends upon the nature of your role, as well as the type of information you may have access to (i.e. knowledge of company financials in advance of earnings releases, or information related to drug approval and clinical trials in the case of biotech and pharma). It's important to familiarize yourself with your company's specific policies, and whether your role will cause you to be more restricted than to the normal trading window alone.
How much equity do VP-level employees typically receive at tech or biotech companies?
Equity grants for VP-level employees vary widely based on company size, function, and industry norms. However, it's common for equity to represent a significant portion of total compensation, often exceeding base salary and eventually reaching multiples of it.
This blog was written by Jeremy Bohne, Principal & Founder of Paceline Wealth Management. Paceline is a fee-only investment advisor serving clients in the Boston area, and on a remote basis throughout the country. Paceline specializes in helping tech and biotech executives, business owners, physicians, and those seeking financial planning services.